The molecular test is used to differentiate bacterial infections, viral infections, and noninfectious disease and to assess ...

OraSure Technologies CEO Carrie Eglinton Manner said in her presentation that the firm's recent $25 million acquisition of ...

The QuickFinder COVID-19/Flu Antigen Self-Test and the QuickFinder COVID-19/Flu Antigen Pro Test detect SARS-CoV-2, influenza A, and influenza B in swab specimens and provide results within 15 minutes ...

Highlights from the first day included updates from several firms about their China businesses and M&A strategies.

Roche plans to release the system in the US to run tests including vitamin D and steroid assays under CLIA before it possibly receives US Food and Drug Administration clearance.

Highlights from the third day included information about Quanterix's new Simoa One platform, expected to launch at the end of ...

Medix said the acquisition adds to its portfolio of raw materials used for in vitro diagnostics development and improves its ability to support immunoassay developers.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

The organization is leveraging its growing bank of whole-slide pathology images to create models that could form the backbone of cancer testing applications.

The partners plan to expand testing for early detection of childhood leukemias and lymphomas, bolster local testing capacity, and conduct a research study.